company-logo

Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.

Imunon Dividend Announcement

Imunon does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Imunon dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Imunon Dividend History

Imunon Dividend Yield

Imunon current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Imunon stock? Use our calculator to estimate your expected dividend yield:

Imunon Financial Ratios

P/E ratio-0.00
PEG ratio0.00
P/B ratio1.52
ROE-57481.16%
Payout ratio0.00%
Current ratio2.30
Quick ratio2.30
Cash Ratio1.89

Imunon Dividend FAQ

Does Imunon stock pay dividends?
Imunon does not currently pay dividends to its shareholders.
Has Imunon ever paid a dividend?
No, Imunon has no a history of paying dividends to its shareholders. Imunon is not known for its dividend payments.
Why doesn't Imunon pay dividends?
There are several potential reasons why Imunon would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Imunon ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Imunon has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Imunon a dividend aristocrat?
Imunon is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Imunon a dividend king?
Imunon is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Imunon a dividend stock?
No, Imunon is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Imunon stocks?
To buy Imunon you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Imunon stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.